Research graph
References from Ionic Diffusion and Drug Release Behavior of Core–Shell-Functionalized Alginate–Chitosan-Based Hydrogel. Local targets link to admitted publications; unresolved targets remain external evidence.
Hydrogel: Preparation, characterization, and applications: A review
10.1016/j.jare.2013.07.006 · 2015 · External reference
pH Sensitive Hydrogels in Drug Delivery: Brief History, Properties, Swelling, and Release Mechanism, Material Selection and Applications
10.3390/polym9040137 · 2017 · External reference
Alginate electrodeposition onto three-dimensional porous Co-Ni films as drug delivery platforms
10.1039/c4cp04389h · 2015 · External reference
Core-shell hydrogel beads with extracellular matrix for tumor spheroid formation
10.1063/1.4918754 · 2015 · External reference
Responsive hydrogels - structurally and dimensionally optimized smart frameworks for applications in catalysis, micro-system technology and material science
10.1039/c3cs60031a · 2013 · External reference
Multi-Stimuli-Responsive Charge-Transfer Hydrogel for Room-Temperature Organic Ferroelectric Thin-Film Devices
10.1021/jacs.6b03811 · 2016 · External reference
The effect of polymer and CaCl2 concentrations on the sulfasalazine release from alginate-N,O-carboxymethyl chitosan beads
10.1186/2194-0517-2-10 · 2013 · External reference
Chemical stimuli-responsive supramolecular hydrogel from amphiphilic tris-urea
10.1002/asia.201000791 · 2011 · External reference
Hydrogels based on cellulose and chitin: fabrication, properties, and applications
10.1039/c5gc02396c · 2016 · External reference
Structural Characterization of Sodium Alginate and Calcium Alginate
10.1021/acs.biomac.6b00378 · 2016 · External reference
Calcium Alginate and Calcium Alginate-Chitosan Beads Containing Celecoxib Solubilized in a Self-Emulsifying Phase
10.1155/2016/5062706 · 2016 · External reference
Alginate: Current Use and Future Perspectives in Pharmaceutical and Biomedical Applications
10.1155/2016/7697031 · 2016 · External reference
Alginate: properties and biomedical applications
10.1016/j.progpolymsci.2011.06.003 · 2012 · External reference
Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art
10.1155/2014/926157 · 2014 · External reference
Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications
10.3390/md13085156 · 2015 · External reference
Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects
10.1586/eri.11.59 · 2011 · External reference
Cytokine-inducing and anti-inflammatory activity of chitosan and its low-molecular derivative
10.1134/s0003683816050070 · 2016 · External reference
NaCl plus chitosan as a dietary salt to prevent the development of hypertension in spontaneously hypertensive rats
10.4142/jvs.2009.10.2.141 · 2009 · External reference
Bioactivity, biocompatibility and antimicrobial properties of a chitosan-mineral composite for periodontal tissue regeneration
10.1590/0104-1428.1835 · 2015 · External reference
Layer-by-layer polyelectrolyte complex coated poly(methacrylic acid) nanogels as a drug delivery system for controlled release: structural effects
10.1039/c4ra05066e · 2014 · External reference
Effect of Bisphosphonates on Orthodontic Tooth Movement─An Update
10.7860/jcdr/2015/11162.5769 · 2015 · External reference
Prevention and treatment of postmenopausal osteoporosis
10.1016/j.jsbmb.2013.09.008 · 2014 · External reference
The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
10.1002/jbmr.2269 · 2014 · External reference
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
10.2147/dhps.s6285 · 2010 · External reference
Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption
10.1016/s0169-409x(00)00061-2 · 2000 · External reference
Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention
2007 · External reference
Bisphosphonates in the treatment of osteoporosis
10.1136/bmj.e3211 · 2012 · External reference
Adverse Effects of Bisphosphonates
10.1007/s00223-010-9364-1 · 2010 · External reference
Measurement of gastrointestinal pH profiles in normal ambulant human subjects
10.1136/gut.29.8.1035 · 1988 · External reference
A microfluidics platform for combinatorial drug screening on cancer biopsies
10.1038/s41467-018-04919-w · 2018 · External reference
Drug dissolution chip (DDC): a microfluidic approach for drug release
10.1002/smll.201100520 · 2011 · External reference
Studies in the development of nateglinide loaded calcium alginate and chitosan coated calcium alginate beads
10.1248/cpb.56.1077 · 2008 · External reference
Eliminating the need for fasting with oral administration of bisphosphonates
10.2147/tcrm.s52291 · 2013 · External reference
Polypyrrole-incorporated conductive hyaluronic acid hydrogels
10.1186/s40824-016-0078-y · 2016 · External reference
Photonic monitoring of chitosan nanostructured alginate microcapsules for drug release
10.1117/12.2084966 · 2015 · External reference
Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis
10.1166/jbn.2013.1482 · 2013 · External reference
